Journals / Annals of Medical Research / 2021 / Cilt: 28 - Sayı: 6

Rosuvastatin's effects on ischemic skin flaps: Facts aboutstatins' effects on skin flap viability

Pages
1176–1182
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Statins were not observed to have favorable effects on critically ischemic skin flapviability through their pleiotropic activity.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: Statins are considered to be protective against ischemic injury because of their pleiotropic effects.
📊
Key Findings & Data:In this animal study, theeffects of high dose (40 mg/kg) rosuvastatin on ischemic skin flaps were investigated.Materials and Methods: Eighteen Wistar Albino male rats randomly divided into the treatment and the sham groups in equal numbers(n=9 in each group).
💡
Conclusion & Impact:Statins were not observed to have favorable effects on critically ischemic skin flapviability through their pleiotropic activity.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Aim: Statins are considered to be protective against ischemic injury because of their pleiotropic effects. In this animal study, theeffects of high dose (40 mg/kg) rosuvastatin on ischemic skin flaps were investigated.Materials and Methods: Eighteen Wistar Albino male rats randomly divided into the treatment and the sham groups in equal numbers(n=9 in each group). Orogastric tubes were used both in the treatment and the sham group. Differently, in our study orogastric feedingstarted one day before the surgery and ended on the postoperative day seven. By this way we aimed to have enough circulatinglevels of agent in acute ischemia. Only the treatment group received rosuvastatin-supplemented water. Twenty-four hours after thefirst gavage application, caudally based, modified McFarlane flaps were elevated in 3x10 cm in size. After flap elevation procedure,the flaps were returned to their original location immediately.Results: The day after the last gavage application on postoperative day seven animals were sacrificed. Thereafter the digital imageswere obtained. The skin biopsies were taken by pathologist from three zones on each flap for histopathological assessment. Skinflap viability rate (p=0.508) and necrosis rate (p=0.453) did not show any difference between the groups Interestingly, the finalweights of the animals were lower than their initial weights, but this was only significant for the study group (p=0.008), not for thesham group (p=0.400). There were no any expectations related with weight change of the animals before the statistical analysis.Conclusion: On the other hand, there are literature studies claiming that the statins are effective to increase ischemic skin flapsviability, this study contradicts earlier studies. Statins were not observed to have favorable effects on critically ischemic skin flapviability through their pleiotropic activity.

🔖

Cite This Article

YAŞAR, E. K., ALAGÖZ, M. Ş., DEMİR, A., TRABZONLU, L. (2022). Rosuvastatin's effects on ischemic skin flaps: Facts aboutstatins' effects on skin flap viability. Annals of Medical Research, Cilt: 28 - Sayı: 6, 1176–1182. https://ajindex.com/articles/445696

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (17)

  1. Trujillo AN, Kesl SL, Sherwood J, et al. Demonstration of the rat ischemic skin wound model. JoVE 2015;98:52637
  2. Waters LM, Pearl RM & Macaulay RM. A comparative analysis of the ability of five classes of pharmacological agents to augment skin flap survival in various models and species: an attempt to standardize skin flap research. Ann Plast Surg1989;23:117-22
  3. Tan CM, Im MJ, Myers RA & Hoopes JE. Effects of hyperbaric oxygen and hyperbaric air on the survival of island skin flaps. Plast Reconstr Surg 1984;73:27- 30
  4. Guba JA. Study of the delay phenomenon in axial pattern flaps in pigs. Plast Reconstr Surg 1979;63:550- 4
  5. Sloan GM & Reinisch JF. Flap physiology and the prediction of flap viability. Hand Clin 1985;1:609-19
  6. Suzuki S, Isshiki N, Ohtsuka M & Maeda T. Experimental study on “delay” phenomenon in relation to flap width and ischaemia. Br J Plast Surg 1988:41:389-94
  7. Vaughan CJ & Gotto Jr AM. Update on statins: 2003. Circulation 2004;110:886-92
  8. De Loecker I & Preiser JC. Statins in the critically ill. Ann Intensive Care 2012;2:19
  9. McFarlane RM, DeYoung G, Henry RA & McFarlane RM. The design of a pedicle flap in the rat to study necrosis and its prevention. Plast Reconstr Surg 1965;35:177-82
  10. Lucas JB. The Physiology and Biomechanics of Skin Flaps. Facial Plast Surg Clin North Am 2017;25:303- 11
  11. Istvan ES & Deisenhofer J. Structural mechanism for statin inhibition of HMG-CoA reductase. Science 2001;292:1160-4
  12. Cortese F, Gesualdo M, Cortese A, et al. Rosuvastatin: Beyond the cholesterol-lowering effect. Pharmacol Res 2016;107:1-18
  13. Liao JK & Laufs U. Pleiotropic effects of statins. Annu Rev Pharmacol Toxicol 2005;45:89-118
  14. Zhou Q, & Liao JK. Pleiotropic effects of statins. Circ J 2010;74:818-26
  15. Miller PS, Smith DG & Jones P. Cost effectiveness of rosuvastatin in treating patients to lowdensity lipoprotein cholesterol goals compared with atorvastatin, pravastatin, and simvastatin (a US Analysis of the STELLAR Trial). Am J Cardiol 2005;95:1314-9
  16. Costa-Scharplatz M, Ramanathan K, Frial T, et al. Cost-effectiveness analysis of rosuvastatin versus atorvastatin, simvastatin, and pravastatin from a Canadian health system perspective. Clin Ther 2008;30:1345-57
  17. Jones PH, Hunninghake DB, Ferdinand KC, et al. Effects of rosuvastatin versus atorvastatin, simvastatin, and pravastatin on non-high-density lipoprotein cholesterol, apolipoproteins, and lipid ratios in patients with hypercholesterol